More than 20 years of healthcare industry experience in R&D, Commercial/Marketing, Corporate Strategy, and Medical Affairs.
Mr. Keith Ho is currently an Director at the Medical Digital Team at Biogen evaluating innovative methods to address medical needs in neuroscience. Previously, he was a member of the Corporate Strategy Office at Merck where he is supporting executive members of the company to develop long-term investment and operating strategies. Many of his initiatives resulted in (re)prioritization of Merck's organic and inorganic investments. Prior to that, Keith was the global market research point for the marketing organization (CV, Diabetes, Thrombosis) at Merck. Prior to Merck, he was a Senior Consultant at Navigant Consulting where he helped his clients in biotech, pharma and medical devices to build portfolio and marketing strategies. He was also trained as a scientist with experience at Bristol-Myers Squibb and Thomas Jefferson University.
Keith graduated with an MBA from Babson College Olin School of Business, Master of Sciences in Pharmacology from Thomas Jefferson University and Bachelor of Sciences in Biological Sciences from Rowan University.